Results 261 to 270 of about 145,743 (338)

Antibody-Drug Conjugate Therapy [PDF]

, 2020
openaire   +1 more source

SHR-A1811, a novel HER2-targeting antibody-drug conjugate, in advanced solid tumors (HORIZON-X): a global phase 1 trial. [PDF]

Signal Transduct Target Ther
Yao H, Yan M, Tong Z, Wu X, Yin Y, Ryu MH, Park JJ, Jiang S, Kim JH, Wang S, Zhong Y, Voskoboynik M, Zhang J, Kaubisch A, Liu C, Chen Y, Im SA, Wu L, Liu Y, Ganju V, Barve M, Li H, Yao G, Yang M, Bao L, Zhao Y, Zhao J, Zhao K, Shen Y, Rong S, Zhu X, Song E.   +31 more
europepmc   +1 more source

Multi‐Scale Interface Engineering of MXenes for Multifunctional Sensory Systems

Advanced Functional Materials, EarlyView.
MXenes, as two‐dimensional transition metal carbides and nitrides, demonstrate remarkable capabilities for multifunctional sensing applications. This review systematically examines multi‐scale interface engineering approaches that enhance sensing performance, enable diverse detection functionalities, and improve system‐level compatibility in MXene ...
Jiaying Liao, Sin‐Yi Pang, Jianhua Hao
wiley   +1 more source

Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma. [PDF]

Front Oncol
Jaime-Casas S, Barragan-Carrillo R, Zugman M, Shah K, Ebrahimi H, Mercier B, Castro DV, Zang PD, LeVee A, Yip W, Li X, Dizman N, Salgia NJ, Zengin Z, Meza L, Hsu J, Nguyen CB, Chehrazi-Raffle A, Pal SK, Tripathi A.   +19 more
europepmc   +1 more source

Bioactive Conductive Ti3C2Tx‐Ce Hydrogel Facilitates Spinal Cord Injury Repair Through ROS Scavenging and Mitochondrial Regulation

Advanced Functional Materials, EarlyView.
Bioactive conductive Ti3C2Tx‐Ce hydrogels with with scavenging ROS and alleviating neuronal mitochondrial dysfunction are exploited for SCI treatment. This functionality is attributed to interfacial activation modification of Ti3C2Tx with Ce3+ ions to in‐situ form Ce(OH)x‐mediated protective layer, which is beneficial to enabling stable intracellular ...
Weikang Wang, Qing Liu, Ang Lv, Yabin Lin, Jiawei Chen, Ning Ding, Chunlei Zhang, Shuai Zhou, Bo Yuan, Weiwei Zhao, Liming Li, Luping Zhang, Fei Huang   +12 more
wiley   +1 more source

Efficacy and safety of antibody-drug conjugates in the treatment of non-small cell lung cancer: a systematic review and meta-analysis of prospective clinical trials

Xiaoni Jin, Weixing Zhao, Bo Li, Yujia Gu, Zirui Li, Wanjing Guo, Xinxin Lü, Jun Jiang   +7 more
openalex   +1 more source

Can Epithelial-Myoepithelial Carcinoma of the Breast Benefit from TROP2 Antibody-Drug Conjugate? [PDF]

Onco Targets Ther
Zhao Q, Luo X, Xing H, Jiang C, Ma J, Tang L.   +5 more
europepmc   +1 more source

Membrane Vesicles from Lacticaseibacillus Casei BL23 Exhibit Antimicrobial Activity Against Escherichia coli and Immunostimulatory Effects on Human Peripheral Blood Mononuclear Cells

Advanced Healthcare Materials, EarlyView.
Membrane vesicles derived from the probiotic Lacticaseibacillus casei BL23 demonstrate antimicrobial properties against Escherichia coli and a potential biological effect in improving the overall survival of C. elegans infected with Pseudomonas aeruginosa. These vesicles stimulated immune responses in primary cells without causing toxicity. Our results
Cecilia L. D'Antoni, Leila Pourtalebi Jahromi, Lorenzo Sana, Ana Paula Domínguez Rubio, Maja Dorfner, Jennifer Munkert, Heike Danzer, Philipp Arnold, Mikhail Lebedev, Esther Zanin, Oscar E. Pérez, Gregor Fuhrmann   +11 more
wiley   +1 more source

Antibody-Drug Conjugate DFRF4539A [PDF]

, 2020
openaire   +1 more source

Receptor-mediated gene delivery employing lectin-binding specificity [PDF]

, 1994
Batra, R. K., Curiel, David T., Garver, R. I., Wagner, Ernst, Wang-Johanning, F.   +4 more
core